title: Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance.
abstract: To determine the impact of fish-oil supplementation on glucose and lipid metabolism in patients with impaired glucose tolerance (IGT), 30 ml fish oil containing 3.8 g eicosapentaenoic acid (EPA; 20:5 omega 3) and 2.5 g docosahexaenoic acid (DHA; 22:5 omega 3) were given to eight obese subjects with IGT (mean +/- SD age 50.3 +/- 8.0 yr) in addition to their regular diet for 2 wk. Studies were performed in randomized order versus an isocaloric control period with a washout phase of 3 wk. Hyperinsulinemic clamp examinations (1 and 10 mU.kg-1.min-1) were performed. Glucose disposal rate (M value) rose from basal 14.3 +/- 5.1 to 17.9 +/- 4.4 mumol.kg-1.min-1 after fish oil (P less than 0.001) during the 1-mU clamp, whereas no change was seen during the 10-mU clamp (without fish oil, 42.2 +/- 8.9 mumol.kg-1.min-1; with fish oil, 45.1 +/- 9.8 mumol.kg-1.min-1;NS). Basal hepatic glucose output remained unaffected by fish oil, whereas fractional glucose clearance after intravenous glucose loading (2.4 mmol/kg body wt, t = 30 min) tended to increase (K value: without fish oil, 2.15 +/- 1.02%/min; with fish oil, 2.74 +/- 1.26%/min; NS). Neither the fasting concentrations of glucose and insulin nor induced glycemia and insulin response during intravenous glucose loading calculated as incremental area under the curve changed after fish-oil supplementation.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: First Medical Department, University of Vienna, Austria.
authors.forename: P
authors.initials: P
authors.lastname: Fasching
authors.forename: K
authors.initials: K
authors.lastname: Ratheiser
authors.forename: W
authors.initials: W
authors.lastname: Waldhäusl
authors.forename: M
authors.initials: M
authors.lastname: Rohac
authors.forename: W
authors.initials: W
authors.lastname: Osterrode
authors.forename: P
authors.initials: P
authors.lastname: Nowotny
authors.forename: H
authors.initials: H
authors.lastname: Vierhapper
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood; D005260:Female; D005395:Fish Oils / Q000008:administration & dosage / Q000627:therapeutic use*; D005527:Food, Fortified; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D011236:Prediabetic State / Q000178:diet therapy*
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D005395:Fish Oils; D007328:Insulin